Search Browse Earnings

DYADIC INTERNATIONAL INC

Nasdaq:DYAI

Biological Products, (No Diagnostic Substances)·JUPITER, FL

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

DYADIC INTERNATIONAL INC — SlamSEC

Revenue

$2.9M

-1.1% YoY

FY 2024

Adj. EBITDA

—

Net Income

-$6.8M

-234.4% margin

FY 2024

EPS (Diluted)

-$0.24

FY 2024

Stock Price

$0.76

2026-03-06

52W Range

—

P/E Ratio

-3.2x

Market Cap

$27.5M

Cash

$6.5M

FY 2024

Total Debt

—

Net Cash

$6.5M

FY 2024

Enterprise Value

$20.9M

Debt / EBITDA

—

EV / EBITDA

—

Employees

—

CEO

Emalfarb Mark A

CFO

Rawson Ping Wang